FDA Inspection
Catalent Argentina S.A.I.C.Catalent Argentina S.A.I.C. – FDA Inspection, May 16, 2014
Record Details
This FDA Inspection record concerns Catalent Argentina S.A.I.C., with an inspection on May 16, 2014, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Catalent Argentina S.A.I.C.
- Inspection Date
- May 16, 2014
- Product Type
- Drugs
View Company Profile
ID · bbc6d871-6804-4a14-8d3f-9768cae31e68
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 881348
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
5- 21 CFR 211.25(a)Training , Education , Experience overall
- 21 CFR 211.198(a)Complaint Handling Procedure
- 21 CFR 211.160(b)(3)Drug products - samples representative, identified properly
- 21 CFR 211.22(d)Procedures not in writing, fully followed
- 21 CFR 211.67(b)Written procedures not established/followed
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Catalent Argentina S.A.I.C.
4| Date | Classification | Office | Project area |
|---|---|---|---|
| August 4, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 22, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 14, 2012 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 2, 2009 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Catalent Argentina S.A.I.C.
- FDA Inspection 1211696 - 2023-08-04
- FDA Inspection 1038458 - 2017-12-22
- FDA Inspection 803767 - 2012-09-14
- FDA Inspection 604132 - 2009-07-02
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.